Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Oncotarget|March 31, 2016
PI3K/Akt promotes feedforward mTORC2 activation through IKKαHan C Dan, Ricardo J Antonia, Albert S Baldwin
Experimental Cell Research|July 10, 2004
BRCA1 185delAG mutation inhibits Akt-dependent, IAP-mediated caspase 3 inactivation in human ovarian surface epithelial cellsNicole C Johnson, Han C Dan, Jin Q Cheng, et al.
American Journal of Cancer Research|December 23, 2015
IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancerZhipeng Li, Zejia Yang, Rena G Lapidus, et al.
The Journal of Biological Chemistry|February 16, 2012
Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53Sungman Park, Donghwa Kim, Han C Dan, et al.
Frontiers in Genetics|August 31, 2018
Co-expression Network Analysis of Biomarkers for Adrenocortical CarcinomaLushun Yuan, Guofeng Qian, Liang Chen, et al.
Cancer Research|November 13, 2003
p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cellsMichael Fraser, Brendan M Leung, Xiaojuan Yan, et al.
The Journal of Biological Chemistry|July 4, 2014
Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα)Han C Dan, Aaron Ebbs, Manolis Pasparakis, et al.
Pageof 3